Morgan Stanley
TNYA icon

Morgan Stanley’s Tenaya Therapeutics TNYA Stock Holding History

Morgan Stanley’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172K Sell
232,293
-36,212
-13% -$27.5K ﹤0.01% 6014
2026
Q1 		$186K Buy
268,505
+60,074
+29% +$44.3K ﹤0.01% 5905
2025
Q4 		$148K Buy
208,431
+41,342
+25% +$56.2K ﹤0.01% 6042
2025
Q3 		$271K Buy
167,089
+51,210
+44% +$51.6K ﹤0.01% 5763
2025
Q2 		$70.8K Sell
115,879
-198,670
-63% -$101K ﹤0.01% 6244
2025
Q1 		$179K Sell
314,549
-1,173,757
-79% -$1.16M ﹤0.01% 5774
2024
Q4 		$2.13M Buy
1,488,306
+1,175,315
+376% +$2.63M ﹤0.01% 4651
2024
Q3 		$604K Buy
312,991
+135,268
+76% +$382K ﹤0.01% 5310
2024
Q2 		$551K Sell
177,723
-138,166
-44% -$571K ﹤0.01% 5248
2024
Q1 		$1.65M Buy
315,889
+83,883
+36% +$401K ﹤0.01% 4690
2023
Q4 		$752K Buy
232,006
+147,983
+176% +$319K ﹤0.01% 5101
2023
Q3 		$214K Sell
84,023
-28,344
-25% -$119K ﹤0.01% 5551
2023
Q2 		$660K Buy
112,367
+31,948
+40% +$186K ﹤0.01% 5078
2023
Q1 		$229K Buy
80,419
+52,559
+189% +$148K ﹤0.01% 5652
2022
Q4 		$56K Buy
27,860
+13,601
+95% +$33.2K ﹤0.01% 6244
2022
Q3 		$41K Buy
14,259
+1,158
+9% +$5.4K ﹤0.01% 6494
2022
Q2 		$75K Buy
13,101
+1,564
+14% +$12.7K ﹤0.01% 6414
2022
Q1 		$135K Sell
11,537
-18,661
-62% -$226K ﹤0.01% 6137
2021
Q4 		$572K Buy
30,198
+27,132
+885% +$591K ﹤0.01% 5464
2021
Q3 		$63K Buy
+3,066
New +$65.9K ﹤0.01% 6612

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley's TNYA Position: Q2 2026 in Review

Morgan Stanley reduced its Tenaya Therapeutics (TNYA) stake by 13% in Q2 2026, selling an estimated $27.5K and leaving 232,293 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #6014.

Morgan Stanley first reported a position in TNYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.13M in Q4 2024. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Morgan Stanley held 232,293 shares of Tenaya Therapeutics worth $172K as of Q2 2026.
  • Morgan Stanley sold 36,212 Tenaya Therapeutics shares in Q2 2026, an estimated $27.5K.
  • Tenaya Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6014 holding.
  • Morgan Stanley first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Tenaya Therapeutics position peaked at $2.13M in Q4 2024.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.